Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcment. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 lakh Covid-19 antibody tests as on September 30. Have enhanced capacity to do RT-PCR tests up to 400 per hour. Revenue for the quarter up 37% as compared to last year and up 171% as compared to the previous quarter. Expects positive for other Diagnostic stocks like Dr Lal Pathlab, Metropolis and Apollo Hospital
Feedback
LALPATHLAB 
Reputation: 29,954 • Oct 7, 2020 4:27 PM
2 Votes
Comment
Share
NSE:LALPATHLAB price when posted: 2,144.55
View Votes